CN106478437A - A kind of preparation method of γ aminovaleric acid ester derivant - Google Patents

A kind of preparation method of γ aminovaleric acid ester derivant Download PDF

Info

Publication number
CN106478437A
CN106478437A CN201610853376.6A CN201610853376A CN106478437A CN 106478437 A CN106478437 A CN 106478437A CN 201610853376 A CN201610853376 A CN 201610853376A CN 106478437 A CN106478437 A CN 106478437A
Authority
CN
China
Prior art keywords
preparation
amino
gamma
reaction
derivative according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610853376.6A
Other languages
Chinese (zh)
Inventor
李泽标
黄虎
曹鸿
林燕峰
吕连岭
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nantong Chang You Medicine Co Science And Technology Ltd
Original Assignee
Nantong Chang You Medicine Co Science And Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nantong Chang You Medicine Co Science And Technology Ltd filed Critical Nantong Chang You Medicine Co Science And Technology Ltd
Priority to CN201610853376.6A priority Critical patent/CN106478437A/en
Publication of CN106478437A publication Critical patent/CN106478437A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/04Formation of amino groups in compounds containing carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/06Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Abstract

The invention discloses a kind of preparation method of γ aminovaleric acid ester derivant,, with N t-butyloxycarbonyl amino 4,4 biphenyl R alanine ester for initiation material, reactions steps include reduction, oxidation, witig reaction and hydro-reduction for it.It is an advantage of the invention that:Process route is brief, fixes a chiral centre in the feed, reduces the generation of chiral impurity;Primary amine is protected, prevents the generation of oxidation impurities;Palladium carbon or ruthenium catalyst tie ligand is applied to carry out the reduction of ethylene linkage, chiral selectivity is high, and reaction yield is high, is suitable for scale industrial production.

Description

A kind of preparation method of gamma-amino pentanoate derivative
Technical field
The present invention relates to the preparation method of gamma-amino pentanoate derivative, specifically, it is related to a kind of (2R, 4S) -4- ammonia The preparation method of base -5- (biphenyl -4- base) -2 methyl valeric acid carbethoxy hydrochloride.
Background technology
Sacubitril is an effective ingredient medicine of cardiotonic agents entresto, an enkephalinase inhibitor, it And Valsartan, the compound preparation of angiotensin ii receptor blocker composition, in order to the painstaking effort of heart failure patient of reducing risks Pipe death and hospitalization chronic heart failure(NYHAII-IV level)Reduce with ejection fraction.The chemistry of Sacubitril is entitled: (2R, 4S) -5- [4- xenyl -4- (3- carboxypropanoyl) amino] -2 methyl valeric acid ethyl ester.No. CAS:149709-62-6.Knot Structure is as shown in Equation 1.
Gamma-amino pentanoate derivative, structure as shown in Equation 2, is the important advanced intermediate of Sacubitril, in chirality It is also easy to produce chiral impurity in the building process of the heart, therefore its quality purity directly affects the quality of final products,
.
Content of the invention
It is an object of the invention to provide a kind of preparation method of gamma-amino pentanoate derivative, it is on sale in a large number with market N- t-butyloxycarbonyl-amino -4,4- biphenyl-R- alanine ester be initiation material, through reduction, oxidation, witig reaction, The reaction such as hydro-reduction obtains product (2R, 4S) -4- amino -5- (biphenyl -4- base) -2 methyl valeric acid carbethoxy hydrochloride, relatively In prior art route, process route is brief, fixes a chiral centre in the feed, reduces the generation of chiral impurity;To primary Amine is protected, and prevents the generation of oxidation impurities;Palladium carbon or ruthenium catalyst tie ligand is applied to carry out the reduction of ethylene linkage, chiral choosing Selecting property is high, and reaction yield is high, is suitable for scale industrial production.
The technical solution used in the present invention is:A kind of preparation method of gamma-amino pentanoate derivative, it is with the N- tert-butyl group Epoxide carbonyl-amino -4,4- biphenyl-R- alanine ester be initiation material, reactions steps include reduction, oxidation, witig reaction, Hydro-reduction, reaction scheme is:
.
Comprise the following steps that:
The preparation of intermediate I:
N- t-butyloxycarbonyl-amino -4,4- biphenyl-R- alanine ester, under reducing agent effect, ester ester group is reduced to alcohol Hydroxyl;
The preparation of intermediate II:
Under catalyst action, oxidized dose of oxidation obtains intermediate II to intermediate I;
The preparation of intermediate III:
Intermediate II and 2- triphenylphosphine vinylpropionic acid ethyl ester occur witig reaction to obtain intermediate III;
The preparation of intermediate IV:
Intermediate III carries out catalytic hydrogenation under catalyst action, and ethylene linkage is reduced;
The preparation of finished product:
Intermediate IV obtains hydrochloric acid product salt under ethanolic hydrogen chloride effect.
Preferably, in the preparation process of intermediate I, N- t-butyloxycarbonyl-amino -4,4- biphenyl-R- alanine ester Mol ratio with reducing agent is 1:1.2~1:2.5.
Preferably, in the preparation process of intermediate I, described reducing agent is the compositionss of sodium borohydride and lithium bromide, boron hydrogen The compositionss of change potassium and lithium bromide or diisobutyl aluminium hydride;Required reaction dissolvent is oxolane, acetonitrile, toluene or dichloro Methane.
Preferably, in the preparation process of intermediate II, intermediate I is 1 with the mol ratio of oxidant:2~1:10.
Preferably, in the preparation process of intermediate II, described oxidant is sodium hypochlorite, oxalyl chloride or dimethyl sulfoxide;Institute Stating catalyst is 2,2,6,6- phenmethylol conversion thewire and potassium bromide;Required reaction dissolvent is oxolane, toluene or dichloro Methane.
Preferably, in the preparation process of intermediate III, intermediate II and 2- triphenylphosphine vinylpropionic acid ethyl ester mole Than for 1:1.1~1:2.5.
Preferably, in the preparation process of intermediate III, required reaction dissolvent is oxolane, methyl tertiary butyl ether(MTBE) or isopropyl Ether, reaction temperature is 20-80 DEG C.
Preferably, in the preparation process of intermediate IV, described catalyst is palladium carbon or diiodo- (paracymene) ruthenium (II) two Aggressiveness and the compositionss of its part;Required reaction dissolvent is ethanol or methanol;Reaction temperature is 25-80 DEG C;Catalyst feeds intake and joins Than the 5-10% for reaction substrate.
Preferably, in the preparation process of finished product, intermediate IV:The mol ratio of ethanolic hydrogen chloride is 1:1~1:8.
Preferably, in the preparation process of finished product, reaction temperature is 25-50 DEG C.
It is an advantage of the invention that:Process route is brief, fixes a chiral centre in the feed, reduces the product of chiral impurity Raw;Primary amine is protected, prevents the generation of oxidation impurities;Application palladium carbon or ruthenium catalyst tie ligand carry out going back of ethylene linkage Former, chiral selectivity is high, and reaction yield is high, is suitable for scale industrial production.
Specific embodiment
Embodiment 1
The preparation of intermediate I:
Under room temperature, by 36g N- t-butyloxycarbonyl-amino -4,4- biphenyl-R- methyl lactamine and 12.2g lithium bromide are placed in In 400mL oxolane, stir 30 minutes, add 5.3g sodium borohydride, then react at room temperature, TLC monitoring reaction;Raw material After reaction completely, evaporated under reduced pressure solvent, add 300mL water, then use ethyl acetate(100mL×3)Extraction;Organic layer is with anhydrous Sodium sulfate is dried, sucking filtration, evaporated under reduced pressure solvent, adds the making beating of 250mL ether, dry in residue, obtains 28.9g white solid and produces Product.Yield:88%.
The preparation of intermediate II:
In 300mL dichloromethane, add 28.9g intermediate I, stirring and dissolving, add 1g catalyst 2,2,6,6- tetramethyl Piperidine oxide, then Deca 20mL kbr aqueous solution, it is cooled to 0 DEG C, subsequent Deca 145g 10% liquor natrii hypochloritises;Drip Finish, be warming up to room temperature reaction, TLC detection reaction;Reaction finishes, and adds 100mL water, stirring, stratification, water in reactant liquor Layer dichloromethane(50mL×2)Extraction;Merge organic faciess, use 100mL saturated sodium bisulfite solution, 100mL saturated aqueous common salt Washing, anhydrous sodium sulfate drying, it is evaporated to dry, obtain 24.4g product.Yield is 85%.
The preparation of intermediate III:
100mL diisopropyl ether, 24.4g intermediate II, stirring and dissolving, Deca 2- triphenylphosphine vinylpropionic acid is added in reaction bulb The diisopropyl ether of ethyl ester(32.6g/200mL)Solution;Drip and finish, be warming up to 50 DEG C of reactions, TLC monitoring reaction;Raw material reaction finishes, and subtracts Pressure is evaporated off diisopropyl ether, then uses 300mL ether to pull an oar, filters, and filter cake uses 300mL ether to pull an oar again, merges organic faciess, and decompression is dense It is reduced to dry 28.6g white solid product.Yield:93%.
The preparation of intermediate IV:
Add 28.6g intermediate IV, 280mL ethanol in hydriding reactor, be stirred at room temperature, nitrogen displacement, add 2.8 g palladium carbons, Nitrogen displacement, logical hydrogen displacement, logical hydrogen, to 1 MP, is heated to 50 DEG C of reactions, TLC monitoring reaction;Reaction finishes, and is down to room temperature, subtracts Pressure concentration of reaction solution, add water 400mL, is heated to reflux 0.5 hour, is cooled to room temperature, stirring and crystallizing, sucking filtration, filter cake 300mL second Alcohol/water making beating, is dried, obtains 28.2g white solid product.Yield:98%.
The preparation of finished product:
Add 28.2g intermediate V in reaction bulb, add 350mL ethanol solution of hydrogen chloride, stirring and dissolving, be heated to 35 DEG C, Then insulation reaction at 30 ~ 35 DEG C, has solid to separate out, TLC monitoring reaction;Reaction finishes, and is cooled to room temperature, sucking filtration, filter cake With washing with alcohol, it is dried, obtains 24.6g white solid product.Yield:96%.
Embodiment 2
The preparation of intermediate I:
Under room temperature, by 40g N- t-butyloxycarbonyl-amino -4,4- biphenyl-R- alanine ethyl ester and 13.2g lithium bromide are placed in In 400mL toluene, stir 30 minutes, add 8.2g potassium borohydride, then react at room temperature, TLC monitoring reaction;Raw material reaction After completely, evaporated under reduced pressure solvent, add 300mL water, then use ethyl acetate(100mL×3)Extraction;Organic layer anhydrous slufuric acid Sodium is dried, sucking filtration, evaporated under reduced pressure solvent, adds the making beating of 300mL ether, dry, obtain 30.5g white solid product in residue. Yield:86%.
The preparation of intermediate II:
In 300mL toluene, add 30.5g intermediate I, stirring and dissolving, add the oxidation of 1g 2,2,6,6- tetramethyl piperidine Thing, then Deca 25mL kbr aqueous solution, it is cooled to 0 DEG C, subsequent Deca 157g 10% liquor natrii hypochloritises;Drip and finish, heat up To room temperature reaction, TLC detection reaction;Reaction finishes, and adds 200mL water, stirring, stratification, water layer first in reactant liquor Benzene(100mL×2)Extraction;Merge organic faciess, use 150mL saturated sodium bisulfite solution, 150mL saturated common salt water washing, anhydrous Sodium sulfate is dried, and is evaporated to dry, obtains 25.8g product.Yield is 83%.
The preparation of intermediate III:
100mL oxolane, 25.8g intermediate II, stirring and dissolving, Deca 2- triphenylphosphine vinyl third is added in reaction bulb The oxolane of acetoacetic ester(35.2g/200mL)Solution;Drip and finish, be warming up to 50 DEG C of reactions, TLC monitoring reaction;Raw material reaction is complete Finish, remove oxolane under reduced pressure, then use 350mL ether to pull an oar, filter, filter cake uses 400mL ether to pull an oar again, merges organic Phase, is evaporated to dry 31.6g white solid product.Yield:96%.
The preparation of intermediate IV:
Add 31.6g intermediate IV, 400mL methanol in hydriding reactor, be stirred at room temperature, nitrogen displacement, add 3.1g diiodo- (right P-Cymene) ruthenium (II) dimer, 0.5g ferrocene ligands (R) -1- [(S) -2- dicyclohexyl phosphino- ferrocenyl]-ethyl two Cyclohexyl phosphine, nitrogen displacement, logical hydrogen displacement, logical hydrogen, to 1 MP, is heated to 50 DEG C of reactions, TLC monitoring reaction;Reaction finishes, fall To room temperature, concentrating under reduced pressure reactant liquor, add water 500mL, is heated to reflux 0.5 hour, is cooled to room temperature, stirring and crystallizing, sucking filtration, filter cake With the making beating of 350mL ethanol/water, it is dried, obtains 30.8g white solid product.Yield:97%.
The preparation of finished product:
Add 30.8g intermediate V in reaction bulb, add 450mL ethanol solution of hydrogen chloride, stirring and dissolving, be heated to 35 DEG C, Then insulation reaction at 30 ~ 35 DEG C, has solid to separate out, TLC monitoring reaction;Reaction finishes, and is cooled to room temperature, sucking filtration, filter cake With washing with alcohol, it is dried, obtains 26.9g white solid product.Yield:95%.
Embodiment 3
The preparation of intermediate I:
Under room temperature, by 50g N- t-butyloxycarbonyl-amino -4, in 4- biphenyl-R- alanine ethyl ester 500mL oxolane, Stirring and dissolving, is cooled to -78 DEG C, then the diisobutyl aluminium hydride solution of Deca 162mL 1N, drips and finishes, and reacts at -78 DEG C 2 hours, then heat to room temperature reaction, TLC monitoring reaction;After raw material reaction is complete, add 200mL saturated ammonium chloride solution, Stirring 30 minutes, removes part oxolane under reduced pressure, adds 200mL water, stirring, then uses ethyl acetate(200mL×3)Extraction Take;Organic layer anhydrous sodium sulfate drying, sucking filtration, evaporated under reduced pressure solvent, add 300mL methyl tertiary butyl ether(MTBE) to beat in residue Slurry, dries, obtains 39.4g white solid product.Yield:89%.
The preparation of intermediate II:
In 400mL dichloromethane, add 39.4g intermediate I, stirring and dissolving, add 1.5g catalyst 2,2,6,6- tetramethyl Phenylpiperidines oxide, then Deca 30mL kbr aqueous solution, it is cooled to 0 DEG C, subsequent Deca 195g 10% liquor natrii hypochloritises; Drip and finish, be warming up to room temperature reaction, TLC detection reaction;Reaction finishes, and adds 200mL water in reactant liquor, stirs, stratification, Water layer dichloromethane(100mL×2)Extraction;Merge organic faciess, use 200mL saturated sodium bisulfite solution, 200mL saturated common salt Water washing, anhydrous sodium sulfate drying, it is evaporated to dry, obtain 32.9g product.Yield is 85%.
The preparation of intermediate III:
200mL methyl tertiary butyl ether(MTBE), 32.9g intermediate II, stirring and dissolving, Deca 2- triphenylphosphine ethylene is added in reaction bulb The methyl tertiary butyl ether(MTBE) of base ethyl propionate(44g/200mL)Solution;Drip and finish, be warming up to 50 DEG C of reactions, TLC monitoring reaction;Raw material Reaction finishes, and removes diisopropyl ether under reduced pressure, then uses 500mL ether to pull an oar, filters, and filter cake uses 500mL ether to pull an oar again, is associated with Machine phase, is evaporated to dry 39.1g white solid product.Yield:94%.
The preparation of intermediate IV:
Add 39.1g intermediate IV, 400mL ethanol in hydriding reactor, be stirred at room temperature, nitrogen displacement, add 3.9 g palladium carbons, Nitrogen displacement, logical hydrogen displacement, logical hydrogen, to 1 MP, is heated to 50 DEG C of reactions, TLC monitoring reaction;Reaction finishes, and is down to room temperature, subtracts Pressure concentration of reaction solution, add water 500mL, is heated to reflux 0.5 hour, is cooled to room temperature, stirring and crystallizing, sucking filtration, filter cake 500mL second Alcohol/water making beating, is dried, obtains 37.7g white solid product.Yield:96%.
The preparation of finished product:
Add 37.7g intermediate V in reaction bulb, add 500mL ethanol solution of hydrogen chloride, stirring and dissolving, be heated to 35 DEG C, Then insulation reaction at 30 ~ 35 DEG C, has solid to separate out, TLC monitoring reaction;Reaction finishes, and is cooled to room temperature, sucking filtration, filter cake With washing with alcohol, it is dried, obtains 33.6g white solid product.Yield:96%.

Claims (10)

1. a kind of preparation method of gamma-amino pentanoate derivative, it is with N- t-butyloxycarbonyl-amino -4,4- biphenyl-R- Alanine ester be initiation material, reactions steps include reduction, oxidation, witig reaction, hydro-reduction it is characterised in that:Specifically Step is as follows:
The preparation of intermediate I:
N- t-butyloxycarbonyl-amino -4,4- biphenyl-R- alanine ester, under reducing agent effect, ester ester group is reduced to alcohol Hydroxyl;
The preparation of intermediate II:
Under catalyst action, oxidized dose of oxidation obtains intermediate II to intermediate I;
The preparation of intermediate III:
Intermediate II and 2- triphenylphosphine vinylpropionic acid ethyl ester occur witig reaction to obtain intermediate III;
The preparation of intermediate IV:
Intermediate III carries out catalytic hydrogenation under catalyst action, and ethylene linkage is reduced;
The preparation of finished product:
Intermediate IV obtains hydrochloric acid product salt under ethanolic hydrogen chloride effect.
2. a kind of gamma-amino pentanoate derivative according to claim 1 preparation method it is characterised in that:Intermediate I Preparation process in, N- t-butyloxycarbonyl-amino -4, the mol ratio of 4- biphenyl-R- alanine ester and reducing agent is 1:1.2 ~1:2.5.
3. a kind of gamma-amino pentanoate derivative according to claim 1 and 2 preparation method it is characterised in that:Middle In the preparation process of body I, described reducing agent is the compositionss of the compositionss, potassium borohydride and lithium bromide of sodium borohydride and lithium bromide Or diisobutyl aluminium hydride;Required reaction dissolvent is oxolane, acetonitrile, toluene or dichloromethane.
4. a kind of gamma-amino pentanoate derivative according to claim 1 preparation method it is characterised in that:Intermediate In II preparation process, intermediate I is 1 with the mol ratio of oxidant:2~1:10.
5. a kind of gamma-amino pentanoate derivative according to claim 1 or 4 preparation method it is characterised in that:Middle In the preparation process of body II, described oxidant is sodium hypochlorite, oxalyl chloride or dimethyl sulfoxide;Described catalyst is 2,2,6,6- tetra- Methyl piperidine oxide and the compositionss of potassium bromide;Required reaction dissolvent is oxolane, toluene or dichloromethane.
6. a kind of gamma-amino pentanoate derivative according to claim 1 preparation method it is characterised in that:Intermediate In III preparation process, intermediate II is 1 with the mol ratio of 2- triphenylphosphine vinylpropionic acid ethyl ester:1.1~1:2.5.
7. a kind of gamma-amino pentanoate derivative according to claim 1 or 6 preparation method it is characterised in that:Middle In the preparation process of body III, required reaction dissolvent is oxolane, methyl tertiary butyl ether(MTBE) or diisopropyl ether, and reaction temperature is 20-80 ℃.
8. a kind of gamma-amino pentanoate derivative according to claim 1 preparation method it is characterised in that:Intermediate In IV preparation process, described catalyst is palladium carbon or the compositionss of diiodo- (paracymene) ruthenium (II) dimer and its part; Required reaction dissolvent is ethanol or methanol;Reaction temperature is 25-80 DEG C;Catalyst charge ratio is the 5-10% of reaction substrate.
9. a kind of gamma-amino pentanoate derivative according to claim 1 preparation method it is characterised in that:Finished product In preparation process, intermediate IV:The mol ratio of ethanolic hydrogen chloride is 1:1~1:8.
10. a kind of gamma-amino pentanoate derivative according to claim 1 or 9 preparation method it is characterised in that:Become In the preparation process of product, reaction temperature is 25-50 DEG C.
CN201610853376.6A 2016-09-27 2016-09-27 A kind of preparation method of γ aminovaleric acid ester derivant Pending CN106478437A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610853376.6A CN106478437A (en) 2016-09-27 2016-09-27 A kind of preparation method of γ aminovaleric acid ester derivant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610853376.6A CN106478437A (en) 2016-09-27 2016-09-27 A kind of preparation method of γ aminovaleric acid ester derivant

Publications (1)

Publication Number Publication Date
CN106478437A true CN106478437A (en) 2017-03-08

Family

ID=58267943

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610853376.6A Pending CN106478437A (en) 2016-09-27 2016-09-27 A kind of preparation method of γ aminovaleric acid ester derivant

Country Status (1)

Country Link
CN (1) CN106478437A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107540574A (en) * 2017-09-19 2018-01-05 成都西岭源药业有限公司 The preparation method of R biphenyl Propanolamines
CN108047093A (en) * 2017-11-29 2018-05-18 南通常佑药业科技有限公司 A kind of preparation method of xenyl aminopropan aldehyde compound
CN110240548A (en) * 2018-03-09 2019-09-17 上虞京新药业有限公司 A kind of preparation method of Cariliprazine intermediate
CN111389468A (en) * 2020-05-09 2020-07-10 青岛科技大学 Application of sulfonated BINAP and polyether functionalized ionic liquid integrated chiral catalyst in asymmetric hydrogenation reaction
CN111450880A (en) * 2020-05-09 2020-07-28 青岛科技大学 Sulfonated BINAP and polyether functionalized ionic liquid integrated chiral catalyst

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5217996A (en) * 1992-01-22 1993-06-08 Ciba-Geigy Corporation Biaryl substituted 4-amino-butyric acid amides
WO2015154673A1 (en) * 2014-04-10 2015-10-15 Zhaoyin Wang Novel prodrugs and combinations for treatment of hypertension and cardiovascular diseases
CN105085322A (en) * 2015-08-15 2015-11-25 浙江永宁药业股份有限公司 Preparation method and intermediate of AHU-377 intermediate and preparation method of intermediate
CN105168205A (en) * 2015-08-18 2015-12-23 泰力特医药(湖北)有限公司 Preparation method for dual inhibitor LCZ696 of angiotensin II receptor and neprilysin

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5217996A (en) * 1992-01-22 1993-06-08 Ciba-Geigy Corporation Biaryl substituted 4-amino-butyric acid amides
WO2015154673A1 (en) * 2014-04-10 2015-10-15 Zhaoyin Wang Novel prodrugs and combinations for treatment of hypertension and cardiovascular diseases
CN105085322A (en) * 2015-08-15 2015-11-25 浙江永宁药业股份有限公司 Preparation method and intermediate of AHU-377 intermediate and preparation method of intermediate
CN105168205A (en) * 2015-08-18 2015-12-23 泰力特医药(湖北)有限公司 Preparation method for dual inhibitor LCZ696 of angiotensin II receptor and neprilysin

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107540574A (en) * 2017-09-19 2018-01-05 成都西岭源药业有限公司 The preparation method of R biphenyl Propanolamines
CN107540574B (en) * 2017-09-19 2021-06-11 成都西岭源药业有限公司 Preparation method of R-biphenylalaninol
CN108047093A (en) * 2017-11-29 2018-05-18 南通常佑药业科技有限公司 A kind of preparation method of xenyl aminopropan aldehyde compound
CN110240548A (en) * 2018-03-09 2019-09-17 上虞京新药业有限公司 A kind of preparation method of Cariliprazine intermediate
CN111389468A (en) * 2020-05-09 2020-07-10 青岛科技大学 Application of sulfonated BINAP and polyether functionalized ionic liquid integrated chiral catalyst in asymmetric hydrogenation reaction
CN111450880A (en) * 2020-05-09 2020-07-28 青岛科技大学 Sulfonated BINAP and polyether functionalized ionic liquid integrated chiral catalyst
CN111389468B (en) * 2020-05-09 2022-11-29 青岛科技大学 Application of sulfonated BINAP and polyether functionalized ionic liquid integrated chiral catalyst in asymmetric hydrogenation reaction
CN111450880B (en) * 2020-05-09 2022-11-29 青岛科技大学 Sulfonated BINAP and polyether functionalized ionic liquid integrated chiral catalyst

Similar Documents

Publication Publication Date Title
CN106478437A (en) A kind of preparation method of γ aminovaleric acid ester derivant
CN108675943A (en) The preparation method of one planting sand library Ba Qu key intermediates
CN114044743B (en) Preparation method of ethyl 2-cyanopropionate
CN104649857B (en) Trifluoromethyl-substituted azide, amine and heterocycle compounds and preparing methods thereof
US9873713B2 (en) Process for synthesizing highly optically active 1,3-disubstituted allenes
CN104829465B (en) A kind of preparation method of 4- isopropylaminos-n-butyl alcohol
CN103012268B (en) Novel preparation method for ivabradine
CN104860980B (en) It is a kind of to be used to synthesize intermediate of Ezetimibe and its preparation method and application
CN112321475B (en) Gamma-amino acid analogue and synthetic method thereof
CN103787921B (en) A kind of method preparing trans 1, the 2-ring diamines of high-optical-purity
CN108084145A (en) Ticagrelor midbody and preparation method thereof
CN110143849B (en) Preparation method of alkynol
CN104326927B (en) A kind of preparation method of 1-[2-amino-1-(4-methoxyphenyl) ethyl] Hexalin sulfate
CN113816837A (en) Synthesis method of 4,4' -dimethoxy triphenylchloromethane
CN110128284B (en) Preparation method of 2-amino-3-biphenylyl propionic acid
CN101723879B (en) Method for synthesizing (R)-3-ethyl piperidine hydrochloride
CN107827916B (en) Synthesis method of (R) - (1-amino-3-methyl) butyl-1-pinanediol borate
CN108203396B (en) Synthesis of enkephalinase inhibitor
CN108033902A (en) A kind of preparation method of his cis-isomer of high-purity Baily department
CN107857731A (en) A kind of process for preparing dexmedetomidine hydrochloride
CN107383076A (en) A kind of synthetic method of the chlorophenylboronic acid pinacol ester of 3 amino 4
CN109384641B (en) Synthesis method of 1, 2-vicinal diol compound
CN112209838B (en) Preparation method of butenaphthol hydrochloride
CN112574132B (en) Preparation method of sarcandra/valsartan sodium
CN113493384A (en) Preparation method of butenafine hydrochloride

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20170308